Tokyo, Japan

Masayoshi Nakoji


 

Average Co-Inventor Count = 7.7

ph-index = 1


Location History:

  • Shizuoka, JP (2016)
  • Tokyo, JP (2019)

Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Masayoshi Nakoji: Innovator in Oligonucleotide Technology

Introduction

Masayoshi Nakoji is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of oligonucleotide technology, holding a total of 3 patents. His work focuses on improving the efficacy of oligonucleotides, which are essential in various biomedical applications.

Latest Patents

Nakoji's latest patents include innovative oligonucleotides designed to enhance affinity for AGO2. One of his notable inventions describes an oligonucleotide with a specific nucleotide residue configuration that binds effectively to adjacent nucleotide residues. This invention aims to improve the knockdown activity of oligonucleotides targeting mRNA associated with diseases. Another patent involves an oligonucleotide featuring a non-natural nucleotide at its 5'-terminal, which also enhances binding capabilities through a unique structural design.

Career Highlights

Throughout his career, Masayoshi Nakoji has worked with reputable companies, including Kyowa Hakko Kirin Co., Limited and Kyowa Kirin Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of oligonucleotide research.

Collaborations

Nakoji has collaborated with notable colleagues such as Fumikazu Shinohara and Asana Makino. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Masayoshi Nakoji is a distinguished inventor whose work in oligonucleotide technology has the potential to impact various medical fields. His innovative patents reflect his commitment to advancing scientific knowledge and improving therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…